Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Effect of two cimetidine regimens on prothrombin time and warfarin pharmacokinetics during long-term warfarin therapy.

Sax MJ, Randolph WC, Peace KE, Chretien S, Frank WO, Braverman AJ, Gray DR, McCree LC, Wyle F, Jackson BJ, et al.

Clin Pharm. 1987 Jun;6(6):492-5. No abstract available. Erratum in: Clin Pharm 1988 Apr;7(4):269.

PMID:
3690995
2.

A comparison of the relative sensitivities of factor VII and prothrombin time measurements in detecting drug interactions with warfarin.

Pitsiu M, Parker EM, Aarons L, Holt B, Rowland M.

Eur J Clin Pharmacol. 1992;42(6):645-9.

PMID:
1623906
3.

The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans.

Niopas I, Toon S, Aarons L, Rowland M.

Eur J Clin Pharmacol. 1999 Jul;55(5):399-404.

PMID:
10456491
4.

Cimetidine and effect of warfarin.

Wallin BA, Jacknowitz A, Raich PC.

Ann Intern Med. 1979 Jun;90(6):993. No abstract available.

PMID:
443703
5.

Effect of erythromycin in patients receiving long-term warfarin therapy.

Weibert RT, Lorentz SM, Townsend RJ, Cook CE, Klauber MR, Jagger PI.

Clin Pharm. 1989 Mar;8(3):210-4. No abstract available.

PMID:
2706893
6.

No pharmacokinetic or pharmacodynamic interaction between rivastatin and warfarin.

Schall R, Müller FO, Hundt HK, Ritter W, Duursema L, Groenewoud G, Middle MV.

J Clin Pharmacol. 1995 Mar;35(3):306-13.

PMID:
7608323
7.

Effect of ciprofloxacin on the pharmacokinetics and pharmacodynamics of warfarin.

Israel DS, Stotka J, Rock W, Sintek CD, Kamada AK, Klein C, Swaim WR, Pluhar RE, Toscano JP, Lettieri JT, Heller AH, Polk RE.

Clin Infect Dis. 1996 Feb;22(2):251-6.

PMID:
8838180
8.

Investigation of patients with abnormal response to warfarin.

Bentley DP, Backhouse G, Hutchings A, Haddon RL, Spragg B, Routledge PA.

Br J Clin Pharmacol. 1986 Jul;22(1):37-41.

9.

Reduction in the plasma clearance rate of warfarin induced by cimetidine.

Bell WR, Anderson KC, Noe DA, Silver BA.

Arch Intern Med. 1986 Dec;146(12):2325-8.

PMID:
3778066
10.

Interaction of sulphinpyrazone with warfarin.

Miners JO, Foenander T, Wanwimolruk S, Gallus AS, Birkett DJ.

Eur J Clin Pharmacol. 1982;22(4):327-31.

PMID:
7106169
11.

Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.

Wright DH, Herman GA, Maes A, Liu Q, Johnson-Levonas AO, Wagner JA.

J Clin Pharmacol. 2009 Oct;49(10):1157-67. doi: 10.1177/0091270009341653.

PMID:
19783710
12.

Losartan does not affect the pharmacokinetics and pharmacodynamics of warfarin.

Kong AN, Tomasko L, Waldman SA, Osborne B, Deutsch PJ, Goldberg MR, Bjornsson TD.

J Clin Pharmacol. 1995 Oct;35(10):1008-15.

PMID:
8568008
13.

Lack of effect of tacrine administration on the anticoagulant activity of warfarin.

Reece PA, Garnett WR, Rock WL Jr, Taylor JR, Underwood B, Sedman AJ, Rajagopalan R.

J Clin Pharmacol. 1995 May;35(5):526-8.

PMID:
7657855
14.

Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

He YL, Sabo R, Riviere GJ, Sunkara G, Leon S, Ligueros-Saylan M, Rosenberg M, Dole WP, Howard D.

Curr Med Res Opin. 2007 May;23(5):1131-8.

PMID:
17519080
15.

Cimetidine: interaction with oral anticoagulants in man.

Serlin MJ, Sibeon RG, Mossman S, Breckenridge AM, Williams JR, Atwood JL, Willoughby JM.

Lancet. 1979 Aug 18;2(8138):317-9.

PMID:
89387
16.

Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers.

Liao S, Palmer M, Fowler C, Nayak RK.

J Clin Pharmacol. 1996 Nov;36(11):1072-7.

PMID:
8973996
17.
18.

Pharmacokinetics and pharmacodynamics of warfarin when coadministered with pentosan polysulfate sodium.

Modi NB, Kell S, Simon M, Vargas R.

J Clin Pharmacol. 2005 Aug;45(8):919-26.

PMID:
16027402
19.

Lack of effect of ranitidine on warfarin action.

Serlin MJ, Sibeon RG, Breckenridge AM.

Br J Clin Pharmacol. 1981 Dec;12(6):791-4.

20.

Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarin.

Miller JW, Skerjanec A, Knadler MP, Ghosh A, Allerheiligen SR.

Pharm Res. 2001 Jul;18(7):1024-8.

PMID:
11496940

Supplemental Content

Support Center